Pfizer
A Simple Strategy to Boost Your Returns
1:35PM 10/18/2011
By John Rosevear, The Motley Fool
Pfizer, Bristol-Myers Squibb, Verizon, McDonald's, Merck, Investing Basics, Chevron
Options: It's a word that makes you shiver with fear or salivate at opportunity. In fact, there's one options strategy that's almost certain to add some extra money to your portfolio over time, without adding lots of risk. It's the technique known as writing covered calls, and it's perfect for times like this.
Shockingly Few Pharma Ads Comply With FDA Guidelines
1:30PM 8/25/2011
Officially, it's the FDA's job to ensure that pharmaceutical ads adhere to guidelines. But the agency's annual compliance budget is $9 million, while drug companies spend $58 billion a year on marketing. So it comes as no surprise that only 18% of ads are in compliance with the rules. But it's still disturbing: This is your health.
The New Chicken and Egg Conundrum: Jobs or Profits?
11:00AM 8/11/2011
By Travis Hoium, The Motley Fool
Google , Pfizer, Campbell Soup Company, Merck, General Motors, Cisco Systems, Whole Foods
Lots of companies are laying off workers, trying to cut costs and improve their profit margins. But how should investors view the news of job cuts at a company? As a sign of deep trouble and worse to come, or as proof of committed management and better times ahead? Here's how to read the pink slips.
Is Celgene the Perfect Stock?
2:00PM 4/06/2011
Company News, Technology, Economy, Investing, Health Care, Genzyme Corporation , Pfizer, Merck, Market News, Investment
With an attractive balance sheet, healthy revenue growth and a solid return on equity, biotech company Celgene looks like a promising stock buy.
Pfizer Sells Capsugel: Will More Asset Sales Follow?
2:15PM 4/04/2011
On Monday, Pfizer announced it would sell its Capsugel business to private-equity firm KKR for $2.375 billion. If the hints the drugmaker has been giving lately are true, the move could be the start of two years of major asset sales. Here's what's ahead for the world's biggest pharmaceutical company.
Next Commerce Chief Will Play a Key Role in Obama's Export Plan
11:30AM 3/11/2011
This week, President Obama announced that he's nominating Commerce Secretary Gary Locke as U.S. Ambassador to China. There are several short-list contenders to replace Locke at Commerce, but the question is: Who would best be able to help Obama double U.S. exports in the next five years?
The Millionaire Class: Most New U.S. Senators are Rich
6:30PM 3/09/2011
Approximately 60% of first-year U.S. senators and 40% of House of Representatives freshmen are worth at least $1 million, according to the Center for Responsive Politics. That makes them far richer than most of the Americans they represent: Just 1% of the country's population has reached the $1 million mark.
Japan Finds No Link Between Vaccines and Child Deaths
12:30PM 3/08/2011
Japan's health ministry says it's continuing its suspension of pediatric vaccines made by Pfizer and Sanofi-Aventis, despite finding no connection between the vaccines and the deaths of four children. Both drugmakers are cooperating with the government and expect to be cleared.
Pfizer and Sanofi-Aventis Vaccines Suspended in Japan
1:50PM 3/07/2011
Two pediatric vaccines have been suspended in Japan after the deaths of four children. Shares of Sanofi-Aventis and Pfizer, which make the drugs, have fallen in midday trading.
In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research and development cuts were on the way.
Most Popular Stories
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Why Your 2012 Tax Bill May Jump By $8,000
Savings Experiment: Tissues vs. Toilet Paper
Why the U.S. Should Get Rid of the $1 Bill
7 Startling Numbers We Now Know About FacebookDailyFinance Wire
Newswire
- Tassimo coffee makers recalled over burn risk
- Greece debt talks fail to reach full deal
- China skirting African corruption in direct aid
- Markets remain optimistic over Greek deal
- Sweden: Europeans need to question pension...
- European central banks to offer new stimulus
- Holiday hits China auto sales in January
- Hard economic times sharpen Spaniards' sneaky...
- The $400-a-year credit card
- Fewer young adults hold jobs than ever before
- Government assistance expands
- Bob Rodriguez: The best advice I ever got
- Adventure travel bargains
- University of Charleston: How we cut tuition...
- Investing for retirement when you're just...
- Get more from a second doctor's opinion
- Media Digest (2/9/2012) Reuters, WSJ, NYT, Bloomberg
- Valuation Reality Check In Whole Foods (WFM, KR, SWY)
- Nearly 200,000 Sign Petition Against Apple Supplier Use
- Facebook Already Amends Its IPO Filing Paperwork (FB)
- Cisco Boosts Earnings & Dividend (CSCO)
- Groupon Headline Loss Trumps Revenue Beat (GRPN)
- 24/7 Wall St. Closing Bell (YUM, DMD, NLY, MS, UBS, AGU, CVS, RL, RAI, TWX, DIS, WYN, BWLD, CSCO, CZR, FFN, TNK, AKAM, NURO)
- Top Earnings Previews For Thursday (ATVI, BG, CBOE, DNKN, EXPE, LNKD, MPEL, NUAN, PEP, PBR, PM, RSG, SIRI, SON, TDC)
Follow Us
